Early Maternal Anemia Linked to ADHD, Autism, and Intellectual Disability in Children
The timing of anemia can make a big difference for the developing fetus.
Read MorePosted by Steve Halasey | Nov 5, 2019 | Research |
The timing of anemia can make a big difference for the developing fetus.
Read MorePosted by Steve Halasey | Aug 13, 2019 | Research |
The study’s detailed information about protein-coding regions of the genome will help to identify biomarkers that will improve diagnosis, clinical care, and outcomes for individuals with autism spectrum disorder.
Read MorePosted by Chaunie Brusie | Jun 27, 2019 | Research |
With the addition of newly identified biomarkers, a test panel under development by NeuroPointDx can now help to identify approximately 41% of children affected by autism spectrum disorder as early as 18 months of age.
Read MorePosted by Steve Halasey | Jan 10, 2019 | Balances, Mass Spectrometry Reagents & Test Kits, Research |
NeuroPointDx has launched its NPDX AA test, which identifies metabolic subtypes associated with autism spectrum disorder.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Research |
NIH small business technology transfer grant supports ‘game-changing’ epigenetic ASD diagnostic test.
Read More